#FLXN Flexion Therapeutics
Flexion Therapeutics Inc #FLXN
Oct 6, 2017 FDA FDA Approval of Zilretta™ (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis (OA) Knee Pain http://ir.flexiontherapeutics.com/releasedetail.cfm?ReleaseID=1043084
There are 27.71% of float short. Wha does everyone think this stock will do next week?
do you think it will go higher? TY